 |
 |
|
|
RESÚMENES MAYO 2008 |
Other Neuropsychiatric Disorders & General Information
(Haga un click en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos
países de la región iberoamericana (algunos artículos requieren ir a la tabla
de contenidos del número actual de la revista)
5! - Cholesterol as a Risk Factor for
Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis
Kaarin J.
Anstey, Darren M. Lipnicki, and Lee-Fay Low
Am J Geriatr Psychiatry
16:343-354, May 2008
3! - Clinical Criteria for the
Diagnosis of Alzheimer Disease: Still Good After All
These Years
Najeeb A. Ranginwala, Linda S. Hynan, Myron
F. Weiner, and Charles L. White III
Am J Geriatr Psychiatry
16:384-388, May 2008
3 - Five-year follow-up of an
evidence-based prescribing intervention
David
Meagher, Ananth Pullela, Marek Meisinger, Niamh Geaney, and Sinead O’Brien
Psychiatric
Bulletin
(2008) 32: 183-186
3! - Disability and treatment of specific
mental and physical disorders across the world
Johan
Ormel, Maria Petukhova, Somnath Chatterji, Sergio
Aguilar-Gaxiola, Jordi
Alonso, Matthias C. Angermeyer, Evelyn J. Bromet, Huibert Burger, Koen Demyttenaere, Giovanni de Girolamo, Josep Maria Haro, Irving Hwang, Elie Karam, Norito Kawakami, Jean
Pierre Lépine, María Elena
Medina-Mora, José Posada-Villa, Nancy Sampson, Kate Scott, T. Bedirhan Üstün, Michael Von Korff, David R. Williams, Mingyuan
Zhang, Ronald C. Kessler
The
British Journal of Psychiatry (2008) 192: 368-375
3 - Pharmacotherapy for erectile
dysfunction
Andrew
Feifer
& Serge Carrier
Expert Opinion on Investigational Drugs. May 2008, Vol. 17, No. 5, Pages 679-690
5 -
A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of
Prolonged-Release OROS Methylphenidate in Adults with
Attention-Deficit/Hyperactivity Disorder
Rossella Medori, J. Antoni Ramos-Quiroga, Miguel Casas, J.J.S. Kooij, Asko
Niemelä, Götz-Erik
Trott, Emma Lee and Jan K. Buitelaar
Biological Psychiatry. Volume 63, Issue 10, 15 May 2008, Pages 981-989
3 - Memantine decreases hippocampal glutamate levels: A magnetic resonance
spectroscopy study
Lidia Glodzik, ,
Kevin G. King, Oded Gonen, Songtao Liu, Susan De
Santi and Mony J. de Leon
GRATIS 3 - Insuficiencias cutáneas debidas
a psicofármacos
María Laura Pérez Roldán, Federico Rebok
Alcmeon,
Año XVII, Vol. 14, Nº 3; marzo de 2008, págs. 5 a 10
GRATIS 3 - Alprazolan sublingual y trastorno de sueño
Norberto Gargiulo, Marcelo Eiras, Sergio Guerstein, Eduardo Wrobel,
Norberto Caruso
Alcmeon, Año XVII, Vol. 14, Nº 3,
marzo de 2008, págs. 42 a 47
3 -
Alternatives to Atypical Antipsychotics for the Management of Dementia-Related
Agitation
Passmore, Michael J; Gardner, David M; Polak,
Yvette; Rabheru, Kiran
Drugs & Aging. 25(5):381-398,
2008
3 -
Clinical characteristics of agitated psychotic patients treated with an oral antipsychotics attended in the emergency room
setting: NATURA study
Alonso Montoya;
Luis San; Jos
Manuel Olivares;
Victor Prez-Sola; Marta
Casillas; Carmen L
pez-Carrero; Pepa
Polavieja; Rodrigo Escobar
International
Journal of Psychiatry in Clinical Practice, Volume 12, Issue 2 2008, pages 127
- 133
3 - Citalopram
in the treatment of women with chronic pelvic pain: an open-label trial
Brown CS, Franks AS, Wan J, Ling FW
J Reprod Med. 2008 Mar;53(3):191-5
3! - Education, cognitive function, and
severity of neuropathology in Alzheimer disease
T.
D. Koepsell, B. F. Kurland, O. Harel,
E. A. Johnson, X. -H. Zhou, and W. A. Kukull
3! - Statins, incident Alzheimer disease, change in
cognitive function, and neuropathology
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, J. L. Bienias, J. F. Kelly, D. A. Evans, and D. A. Bennett
5 - A randomized placebo-controlled
trial of Ginkgo biloba for the prevention of
cognitive decline
H. H.
Dodge, T. Zitzelberger, B. S. Oken, D. Howieson, and J. Kaye
3 - Whole-brain atrophy rate in
Alzheimer disease. Identifying fast progressors
J.
D. Sluimer, H. Vrenken, M.
A. Blankenstein, N. C. Fox, P. Scheltens,
F. Barkhof, and W. M. van der
Flier
3! - Subsequent Risk of
Hospitalization for Neuropsychiatric Disorders in Patients With
Rheumatic Diseases. A Nationwide Study From
Kristina Sundquist, Xinjun Li,
Kari Hemminki, Jan Sundquist
Arch Gen Psychiatry. 2008;65(5):501-507
3! - Breastfeeding and Child
Cognitive Development. New Evidence From a Large Randomized Trial
Michael S. Kramer, Frances Aboud, Elena Mironova, Irina Vanilovich, Robert W. Platt, Lidia Matush,
Sergei Igumnov, Eric Fombonne,
Natalia Bogdanovich, Thierry Ducruet,
Jean-Paul Collet, Beverley Chalmers, Ellen Hodnett, Sergei Davidovsky, Oleg Skugarevsky, Oleg Trofimovich, Ludmila Kozlova, Stanley Shapiro,
for the Promotion of Breastfeeding Intervention Trial (PROBIT) Study Group
Arch Gen Psychiatry. 2008;65(5):578-584
5 - Effects of fluoxetine
on disease activity in relapsing multiple sclerosis: a double-blind,
placebo-controlled, exploratory study
J P Mostert, F Admiraal-Behloul,
J M Hoogduin, J Luyendijk,
D J Heersema, M A van Buchem,
J De Keyser
J Neurol Neurosurg
Psychiatry. Published Online First: 1
May 2008
5 - Olanzapine Plus Dialectical
Behavior Therapy for Women With
High Irritability Who Meet Criteria for Borderline Personality Disorder: A
Double-Blind, Placebo-Controlled Pilot Study
Marsha M. Linehan, Joshua D. McDavid,
Milton Z. Brown, Jennifer H. R. Sayrs, and Robert J.
Gallop
J Clin Psychiatry May 6,
2008: e1-e7
GRATIS 3 - Making sense of neuroimaging
in psychiatry
G. S. Malhi, J. Lagopoulos
Acta Psychiatrica Scandinavica 2008;
117 (2), 100–117
3 - Pharmacological treatment of fibromyalgia syndrome
C. Sommer, W. Häuser,
M. Berliner, W. Brückle, S. Ehlers,
K. Mönkemöller, B. Moradi, F. Petzke, N. Üçeyler, R. Wörz,
E. Winter und D.O. Nutzinger
Der Schmerz. On Line First. May 2008
3! - Etiology of Chronic Fatigue Syndrome: Testing Popular
Hypotheses Using a National Birth Cohort Study
Samuel
B. Harvey, Michael Wadsworth, Simon Wessely, and
Matthew Hotopf
Psychosomatic Medicine
70:488-495 (2008)
5 - Efficacy and safety of tarenflurbil
in mild to moderate Alzheimer's disease: a randomised phase II trial
Gordon K Wilcock , Sandra
E Black , Suzanne B Hendrix , Kenton H Zavitz , Edward A Swabb , Mark A Laughlin and on behalf of the Tarenflurbil Phase II Study investigators
The Lancet Neurology. Volume 7, Issue 6, June 2008, Pages 483-493
3 -
Methylphenidate for the Treatment of Apathy in Alzheimer Disease: Prediction of
Response Using Dextroamphetamine Challenge
Herrmann,
Nathan; Rothenburg, Lana S; Black, Sandra E; Ryan,
Michelle; Liu, Barbara A; Busto, Usoa E; Lanctot, Krista L
Journal of Clinical
Psychopharmacology. 28(3):296-301,
June 2008
3 - Effects of Zolpidem on Cyclic Alternating Pattern, an Objective Marker
of Sleep Instability, in Japanese Patients with Psychophysiological
Insomnia: A Randomized Crossover Comparative Study with Placebo
M. Ozone, T. Yagi,
H. Itoh, Y. Tamura, Y. Inoue, N. Uchimura, M. Sasaki, T. Shimizu, M. G. Terzano, L. Parrino
Pharmacopsychiatry 2008; 41: 106-114
3! - Elderly suicide rates:
cross-national comparisons of trends over a 10-year period
Ajit Shah,
International
Psychogeriatrics (2008), 20:673-686
3 - Discontinuation of donepezil for the treatment of Alzheimer's disease in
geriatric practice
Hiroyuki Umegaki,
Akio Itoh, Yusuke Suzuki and Toshitaka
Nabeshima
International Psychogeriatrics (2008), 20:800-806
3! - Better cognitive performance in elderly taking
antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: The
Majid Fotuhi, Peter
P. Zandi, Kathleen M. Hayden, Ara S. Khachaturian, Christine A. Szekely, Heidi Wengreen, Ronald G. Munger, Maria C. Norton, JoAnn T. Tschanz, Constantine G. Lyketsos, John C.S. Breitner and Kathleen Welsh-Bohmer
Alzheimer's and Dementia. Volume 4, Issue 3, May 2008, Pages 223-227
3 - Immunological
disturbance and infectious disease in anorexia nervosa: a review
Rhonda F. Brown, Roger Bartrop, C. Laird
Acta Neuropsychiatrica 2008;20 (3),
117–128
3 - The pharmacological treatment
of premature ejaculation.
Giuliano F, Hellstrom WJ
BJU Int. 2008 May 15. [Epub
ahead of print]
3 - Time to remission for eating
disorder patients: A 2 & 1/2-year follow-up study of outcome and predictors
Loa Clausen
Nordic Journal of
Psychiatry, Volume 62, Issue 2 2008 , pages 151 - 159
3 - Current pharmacologic treatment of dementia: a clinical
practice guideline from the
Qaseem A, Snow V,
Cross JT Jr, Forciea MA,
Hopkins R Jr, Shekelle P,
Adelman A, Mehr D, Schellhase
K, Campos-Outcalt D, Santaguida
P, Owens DK
Ann Intern Med 2008 Mar 4;148(5):370-8
3! - Antipsychotic Therapy and
Short-term Serious Events in Older Adults With
Dementia
Paula A. Rochon,
Sharon-Lise Normand, Tara Gomes, Sudeep
S. Gill, Geoffrey M. Anderson, Magda Melo, Kathy Sykora, Lorraine Lipscombe, Chaim M. Bell, Jerry
H. Gurwitz
Arch Intern Med. 2008;168(10):1090-1096
3! -
Exploring the Correlates of Suicide Attempts Among
Individuals With Major Depressive Disorder: Findings From the National
Epidemiologic Survey on Alcohol and Related Conditions
James M. Bolton,
Shay-Lee Belik,
J Clin Psychiatry May 27,
2008: e1-e11
5 - Escitalopram
and Problem-Solving Therapy for Prevention of Poststroke
Depression. A Randomized Controlled Trial
Robert G. Robinson, Ricardo E.
Jorge, David J. Moser, Laura Acion, Ana Solodkin, Steven L. Small, Pasquale Fonzetti,
Mark Hegel, Stephan Arndt
4 - Safety and efficacy of galantamine in subjects with mild cognitive impairment
B. Winblad,
S. Gauthier, L. Scinto, H. Feldman, G. K. Wilcock, L. Truyen, A. J. Mayorga, D. Wang, H. R. Brashear, J. S. Nye, and The
GAL-INT-11/18 Study Group
3 - Diagnostic and treatment
challenges of chronic fatigue syndrome: role of immediate-release
methylphenidate
José Ramón Valdizán
Usón and María Ángeles Idiazábal Alecha
Expert Review of Neurotherapeutics. June 2008, Vol. 8, No. 6, Pages 917-927
3 - Effects
of Stimulant Medication on Neuropsychological Functioning in Young Adults With Attention-Deficit/Hyperactivity Disorder
Joseph Biederman, Larry J. Seidman,
Carter R. Petty, Ronna Fried, Alysa
E. Doyle, Daniel R. Cohen, Deborah C. Kenealy, and
Stephen V. Faraone
J Clin Psychiatry May 27,
2008: e1-e7
3 - Somatic comorbidities of
irritable bowel syndrome: A systematic analysis
Andrea Riedl, Marco Schmidtmann, Andreas Stengel, Miriam Goebel, Anna-Sophia Wisser, Burghard F. Klapp and
Hubert Mönnikes,
Journal of Psychosomatic Research. Volume 64, Issue 6, June 2008, Pages 573-582
3! - Gastrointestinal symptoms in primary care: Prevalence
and association with depression and anxiety
